These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32936615)

  • 61. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice.
    Kunath K; von Harpe A; Petersen H; Fischer D; Voigt K; Kissel T; Bickel U
    Pharm Res; 2002 Jun; 19(6):810-7. PubMed ID: 12134951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Toxicology of antisense therapeutics.
    Jason TL; Koropatnick J; Berg RW
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):66-83. PubMed ID: 15519609
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PEGylation site-dependent structural heterogeneity study of monoPEGylated human parathyroid hormone fragment hPTH(1-34).
    Liu CY; Li X; Chen WY; Chang LC; Chen YF; Chen HL; Sun YS; Lai HY; Huang EW
    Langmuir; 2014 Sep; 30(38):11421-7. PubMed ID: 25168862
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
    Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PEG-PEI copolymers for oligonucleotide delivery to cells and tissues.
    Lutz GJ; Sirsi SR; Williams JH
    Methods Mol Biol; 2008; 433():141-58. PubMed ID: 18679622
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics of oligonucleotides.
    Agrawal S; Zhang R
    Ciba Found Symp; 1997; 209():60-75; discussion 75-8. PubMed ID: 9383569
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
    Zhang G; Han B; Lin X; Wu X; Yan H
    J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Poly(l-glutamic acid)-g-poly(ethylene glycol) external layer in polyelectrolyte multilayer films: Characterization and resistance to serum protein adsorption.
    Szczepanowicz K; Kruk T; Świątek W; Bouzga AM; Simon CR; Warszyński P
    Colloids Surf B Biointerfaces; 2018 Jun; 166():295-302. PubMed ID: 29604572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of PEG architecture and molecular weight in the gene transfection performance of PEGylated poly(dimethylaminoethyl methacrylate) based cationic polymers.
    Venkataraman S; Ong WL; Ong ZY; Joachim Loo SC; Ee PL; Yang YY
    Biomaterials; 2011 Mar; 32(9):2369-78. PubMed ID: 21186058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
    Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro and in vivo characteristics of core-shell type nanogel particles: optimization of core cross-linking density and surface poly(ethylene glycol) density in PEGylated nanogels.
    Tamura M; Ichinohe S; Tamura A; Ikeda Y; Nagasaki Y
    Acta Biomater; 2011 Sep; 7(9):3354-61. PubMed ID: 21664304
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interaction of chemically modified antisense oligonucleotides with sense DNA: a label-free interaction study with reflectometric interference spectroscopy.
    Sauer M; Brecht A; Charissé K; Maier M; Gerster M; Stemmler I; Gauglitz G; Bayer E
    Anal Chem; 1999 Jul; 71(14):2850-7. PubMed ID: 10424171
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W; Huang Z; MacKay JA; Grube S; Szoka FC
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.